WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer

Conditions:   Hypopharynx Squamous Cell Carcinoma;   Oral Cavity Squamous Cell Carcinoma;   Larynx Cancer
Interventions:   Drug: AZD1775;   Drug: Cisplatin;   Radiation: Radiotherapy
Sponsors:   University of Birmingham;   AstraZeneca;   Cancer Research UK
Not yet recruiting - verified January 2017

http://ift.tt/2jTSrNc